James Inkster, Msc., SFU/TRIUMF Simplifying the Preparation of 18 F-based Biomolecular Imaging Agents Through ‘Click’ Chemistry CANADA’S NATIONAL LABORATORY.

Slides:



Advertisements
Similar presentations
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété
Advertisements

Nordion and TRIUMF A 37 Year Partnership EW Vogt Science Symposium February 7 th 2015 Presented by: Jerry Porter, Director Nordion Vancouver.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Proposal for ½ MW photo-fission driver based on TESLA 1.3 GHz SCRF technology (Shane Koscielniak, 09 Nov 2007) Electron Linac CANADA ’ S NATIONAL LABORATORY.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Enantioselective Synthesis of Pactamycin, a Complex Antitumor Antibiotic Doug Kenny Science, 12 April 2013.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Niels Tolstrup et al. summarized by Ki-Roo Shin
Targeted Delivery of Nanomedicine WP 5: Target cell uptake and intracellular trafficking of siRNA/pDNA nanoparticles WP leader: Ghent Laboratory of General.
RADIOPHARMACEUTICAL R & D
Proposal for ½ MW photo-fission driver based on TESLA 1.3 GHz SCRF technology (Shane Koscielniak, 09 Nov 2007) Electron Linac CANADA ’ S NATIONAL LABORATORY.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
SRF Activities at TRIUMF & PAVAC
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Steven McDonald May TRIUMF Site Report CANADA’S NATIONAL LABORATORY FOR PARTICLE AND NUCLEAR PHYSICS Owned and operated as a joint.
Dionicio Siegel – Accessing, Understanding, and Optimizing Compounds We are interested in: Providing synthetic access to unique compounds with promising.
A general method for labeling siRNA by click chemistry with fluorine-18 for in vivo PET imaging Flagothier J 1, Mercier F 1, Kaisin G 1, Teller N 2, Warnock.
Novel approach to production of high specific activity [ 18 F]-Sodium Tetrafluoroborate Alex Khoshnevisan 1, Jennifer D. Young 1, Gareth E. Smith 2, Alex.
TRIUMF-MDS-Nordion Radiopharmaceutical R&D Collaboration TRIUMF and MDSN signed MOU Both agreed to invest $250K each into a new radiochem lab in the MHESA.
24 th June 2015 Biological evaluation of 64 Cu-radiolabeled gastrin-releasing peptide receptors antagonist conjugated to DOTHA 2 a new bifunctional chelator.
Reporter : Cheng-Yu Chung Date:2013/12/27 Advisor : Prof.Wen-Chang Chen Click Chemistry.
CANADA’S NATIONAL LABORATORY FOR PARTICLE AND NUCLEAR PHYSICS Owned and operated as a joint venture by a consortium of Canadian universities via a contribution.
Databases at TRIUMF Andrew Wong CANADA’S NATIONAL LABORATORY FOR PARTICLE AND NUCLEAR PHYSICS Owned and operated as a joint venture by a consortium of.
NANOTECHNOLOGIES: THE NEW GENERATION OF MEDICINE Dr Mariano Licciardi.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
CZ3253: Computer Aided Drug design Lecture 1: Drugs and Drug Development Part I Prof. Chen Yu Zong Tel:
LABORATOIRE NATIONAL CANADIEN POUR LA RECHERCHE EN PHYSIQUE NUCLÉAIRE ET EN PHYSIQUE DES PARTICULES Propriété d’un consortium d’universités canadiennes,
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Nuclear Medicine division status Jean-Michel Poutissou 7 th April 2011.
LABORATOIRE NATIONAL CANADIEN POUR LA RECHERCHE EN PHYSIQUE NUCLÉAIRE ET EN PHYSIQUE DES PARTICULES Propriété d’un consortium d’universités canadiennes,
The Most Exotic Nuclei on Earth: Precision Experiments on Halo Nuclei Maxime Brodeur UBC graduate student, TRIUMF for the TITAN collaboration CANADA’S.
Use of Ethidium Bromide in gel electrophoresis  Ethidium bromide is an intercalating agent commonly used as a fluorescent tag (nucleic acid stain) in.
January 18, 2013 All Hands January ARIEL Completion and the next 5 Year Plan.
Click chemistry for chitosan nanocarriers and biomaterials Ph.D. Student: Ingólfur Magnússon Instructor: Már Másson 7. June 2013 Research day.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Synthesis of New Scaffolds via Bisalkyne Cyclizations Catalyzed by Triflic Acid Jaime Alvarez Duque, Kyle Strom, John K. Snyder Boston University, Department.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
BERAC April 2004 Radiopharmaceutical Sub- committee Report.
Progress in Cancer Therapy Following Developments in Biopharma
Nanotechnology in Medicine Krešimir Pavelić, Marijeta Kralj and Damir Kralj Division of Molecular Medicine and Division of Material Chemistry Ruđer.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Cell Incorporation Studies with 99m Tc Labeled Methotrexate Loaded Chitosan Nanoparticles for Breast Cancer Diagnosis Meliha Ekinci, MSc. Pharm. Ege University,
Molecular Biomarkers & Targets an overview Michael Messenger NIHR Diagnostic Evidence Co-Operative & Leeds Cancer Research UK Centre.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Small Molecules that Enhance the Pharmacological Effects of Oligonucleotides Melissa Porter 1, Bing Yang 1, Canhong Cao 1, Xin Ming 1, Emily Hull-Ryde.
Synthetic Chemistry for the Life Sciences Dial – a – Molecule Workshop, University of Liverpool Jan-12 Where / how can chemistry make greater contribution.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Lipofection (or liposome transfection) is a technique used to inject genetic material into a cell by means of liposomes, which are vesicles that can easily.
Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété.
Supercool Neutrons (Ultracold Neutrons) Jeff Martin University of Winnipeg Skywalk 2007 research supported by Natural Sciences and Engineering Research.
Developing a DNA pull-down assay to identify Pt(II) bound DNA Sequences Maria V. Guevara, 1 Emily Sutton 2 and Victoria J. DeRose 2 1 Herbert Wertheim.
Radiochemistry ANTÓNIO PAULO
Subatomic Physics Detector Lab
tdct – a Capfast replacement
Oxford Synthesis Connections
Nuclear magnetic resonance NMR spectroscopy is a key analytical technique for structure elucidation of a wide range of materials from small molecules to.
Bioconjugation Bioconjugation is the process of joining of biomolecules to other biomolecules, small molecules, and polymers by chemical or biological.
Drug Affinity Responsive Target Stability (DARTS).
Aromatization using gold catalysis
Consortium: National networks in 16 European countries.
1,3-Dipolar Cycloadditions
Consortium: National networks in 16 European countries.
R.Keitel Epics Collaboration Meeting, Padova, Oct. 2008
CLICK CHEMISTRY AND DRUG DISCOVERY
Nanoparticles For Delivery of DNA Therapeutics
Development of 213Bi-labelled somatostatin analogues: Finding the optimal match between radiometal and chelator Ahenkorah Sa,c,d., Cleeren Fd., Ooms Ma.,
Presentation transcript:

James Inkster, Msc., SFU/TRIUMF Simplifying the Preparation of 18 F-based Biomolecular Imaging Agents Through ‘Click’ Chemistry CANADA’S NATIONAL LABORATORY FOR PARTICLE AND NUCLEAR PHYSICS Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada LABORATOIRE NATIONAL CANADIEN POUR LA RECHERCHE EN PHYSIQUE NUCLÉAIRE ET EN PHYSIQUE DES PARTICULES Propriété d’un consortium d’universités canadiennes, géré en co-entreprise à partir d’une contribution administrée par le Conseil national de recherches Canada

Biomolecules as molecular imaging agents  Why biomolecules? Established synthetic procedures Exquisite specificity

Biomolecules as molecular imaging agents  Why biomolecules? Established synthetic procedures Exquisite specificity  Why not? Often requires a complex radiosynthesis Certain species may have issues with in vivo stability, bioavailability Most biomolecules are incompatible with many radiolabelling protocols

‘Click’ is a concept Kolb, H.C. & Sharpless, K.B. Drug Discovery Today 2003, 8, ,2,3- triazoles epoxide ring openings oximes hydrazones

[ 18 F]FPy5yne: an optimized 18 F- based bifunctional molecule  Efficient incorporation of [ 18 F]fluoride via 2-substitued pyridinyl nucleophilic heteroaromatic substitution  Efficient bioconjugation via Huisgen [3+2] cycloaddition reaction Inkster, J. A. H. et al. Journal of Labelled Compounds and Radiopharmaceuticals 2008, 51,

A typical radioTLC Radiochemical Yield: 89.6%±2.0% (n=4) 18 F -

Peptide labelling with [ 18 F]FPy5yne

Co-injections: (A) [ 18 F]FPy5yne (B) 18 F-Peptide RCY = 89.6%±2.0% (n =4) (A)(B)

Proposed biological applications i.e. Where are we going with all this? 18 F-BBN [ 18 F-bombesin(7-14)]  GRP receptors expressed in ~65% breast cancers*  18 F analogs of bombesin have been prepared 18 F-BVD15  NPY1 receptors expressed in 58%-85% breast cancers*  Attractive target, not yet labelled with 18 F 18 F-Senktide (a NK-3 receptor agonist)  Neuropeptide analog of substance P *Reubi J.C. European Journal of Nuclear Medicine 2002, 29, 855.

Same Prosthetic Group, Different Biomolecule

Why make radioactive DNA? Robinson, R. PLoS Biology, 2004, 2,

“I’ve seen the future, brother: it is murder.” –L.Cohen The challenge: the in vivo delivery of nucleic-acid based radiotracers into target cells, followed by retention of the probe by an antisense mechanism Abes, R. et al., Journal of Peptide Science 2008, 14, Juliano, R. et al. Nucleic Acids Research 2008, 36, Debart, F. et al. Current Topics in Medicinal Chemistry 2007, 7, F CP Peptide Oligo CP Peptide Oligo 18 F

Conclusion & Acknowledgements  The goal: t o employ TRIUMF LS’s expertise in synthetic organic and radiochemistry to develop simple, efficient and high-impact protocols for the preparation of biological radiopharmaceuticals  The Team PET Group (TRIUMF) Tim Storr (SFU) Mike Adam (UBC/TRIUMF) David Perrin (UBC) Fr anç ois Bernard (BC Cancer) Brigitte Guérin (U. de Sherbrooke) Tom Ruth

“I’ve seen the future, baby: it is murder.” –L.Cohen The challenge: the in vivo delivery of nucleic-acid based radiotracers into target cells, followed by retention of the probe by an antisense mechanism Some options:  Mismatched support strands  Cell-penetrating peptide-ON conjugates Tat(48-60), Transportan  Guanidino ON 18 F-(R-Ahx-R) 4 -PNA or 18 F-(R-Ahx-R) 4 -PMO Abes, R. et al., Journal of Peptide Science 2008, 14, Juliano, R. et al. Nucleic Acids Research 2008, 36, Debart, F. et al. Current Topics in Medicinal Chemistry 2007, 7,

Peptide labeling with Tri[ 18 F]fluoroarylborates  an application of technology developed by the Perrin lab.

[ 18 F]Fluorination of Sulfonyl Chlorides

Scavenging [ 18 F]Fluoride from Aqueous Solutions with Cationic Boranes (19) (20)

A Maxim “Synthetic organic chemistry is hard work. Radiochemistry is just hard.” - J. Inkster

A Maxim “Synthetic organic chemistry is hard work. Radiochemistry is just hard.” - J. Inkster “And don’t even ask me about radiobioconjugate chemistry…”

18 F-labelled Bombensein(7-14)